Vertex Pharmaceuticals Shares Gain After FDA Approves Non-Opioid Pain Drug

business people have a meeting about company statistics

Shares of Vertex Pharmaceuticals rose after Journavx, the company’s oral non-opioid pain medication, received Food and Drug Administration approval.

OK